Cargando…
The dark side of SOX2: cancer - a comprehensive overview
The pluripotency-associated transcription factor SOX2 is essential during mammalian embryogenesis and later in life, but SOX2 expression can also be highly detrimental. Over the past 10 years, SOX2 has been shown to be expressed in at least 25 different cancers. This review provides a comprehensive...
Autores principales: | Wuebben, Erin L., Rizzino, Angie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546531/ https://www.ncbi.nlm.nih.gov/pubmed/28388544 http://dx.doi.org/10.18632/oncotarget.16570 |
Ejemplares similares
-
Sox2 Expression Is Regulated by a Negative Feedback Loop in Embryonic Stem Cells That Involves AKT Signaling and FoxO1
por: Ormsbee Golden, Briana D., et al.
Publicado: (2013) -
The SOX2-Interactome in Brain Cancer Cells Identifies the Requirement of MSI2 and USP9X for the Growth of Brain Tumor Cells
por: Cox, Jesse L., et al.
Publicado: (2013) -
SOX2 functions as a molecular rheostat to control the growth, tumorigenicity and drug responses of pancreatic ductal adenocarcinoma cells
por: Wuebben, Erin L., et al.
Publicado: (2016) -
Tumor quiescence: elevating SOX2 in diverse tumor cell types downregulates a broad spectrum of the cell cycle machinery and inhibits tumor growth
por: Metz, Ethan P., et al.
Publicado: (2020) -
Musashi2 Is Required for the Self-Renewal and Pluripotency of Embryonic Stem Cells
por: Wuebben, Erin L., et al.
Publicado: (2012)